Integrated Diagnostics Holdings plc (LON:IDHC - Get Free Report)'s share price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 0.42 ($0.01) and traded as low as GBX 0.36 ($0.00). Integrated Diagnostics shares last traded at GBX 0.36 ($0.00), with a volume of 13,812 shares changing hands.
Integrated Diagnostics Price Performance
The stock has a market capitalization of £10.86 billion, a price-to-earnings ratio of 13.72, a price-to-earnings-growth ratio of 7.65 and a beta of 0.59. The business's 50 day simple moving average is GBX 0.42 and its 200-day simple moving average is GBX 0.41. The company has a debt-to-equity ratio of 45.72, a quick ratio of 0.75 and a current ratio of 1.59.
Integrated Diagnostics Company Profile
(
Get Free Report)
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. The Group's core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia).
Featured Articles
Before you consider Integrated Diagnostics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integrated Diagnostics wasn't on the list.
While Integrated Diagnostics currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.